Literature DB >> 19800092

IL-10 is pathogenic during the development of coxsackievirus B4-induced chronic pancreatitis.

Rui Gu1, Anae Shampang, Andrew Reilly, Dusti Fisher, William Glass, Arlene I Ramsingh.   

Abstract

Using a mouse model of coxsackievirus B4 (CVB4-V)-induced chronic pancreatitis, we investigated whether cytokines are involved in the progression of acute disease to chronic inflammatory disease. We show that IL-10 contributed to the development of chronic pancreatitis since acute disease resolved when IL-10 was absent or when IL-10 signaling was disrupted. We explored the underlying mechanisms by which IL-10 affected disease progression, using a novel approach to assess immunological events occurring in situ. Multiple markers that define functional innate immune responses and functional T cell responses were monitored over the course of CVB4-V infection of wild-type and IL-10 knockout mice, using a multiplex transcriptional profiling approach. We show that high levels of IL-10 early during infection were associated with delayed innate and T cell responses. Furthermore, high IL-10 production correlated with altered kinetics of T regulatory responses indicating a disruption in the balance between effector and regulatory T cell responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19800092      PMCID: PMC2783446          DOI: 10.1016/j.virol.2009.09.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

Review 1.  Host immune responses to coxsackievirus B3.

Authors:  S Huber
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 2.  The role of TLR activation in inflammation.

Authors:  I Sabroe; L C Parker; S K Dower; M K B Whyte
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

3.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Authors:  R T Gazzinelli; M Wysocka; S Hieny; T Scharton-Kersten; A Cheever; R Kühn; W Müller; G Trinchieri; A Sher
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

Review 4.  Morbidity and mortality in 602 patients with acute pancreatitis seen between the years 1980-1994.

Authors:  P G Lankisch; S Burchard-Reckert; M Petersen; D Lehnick; C A Schirren; H Köhler; F Stöckmann; H J Peiper; W Creutzfeldt
Journal:  Z Gastroenterol       Date:  1996-06       Impact factor: 2.000

5.  IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.

Authors:  C A Hunter; L A Ellis-Neyes; T Slifer; S Kanaly; G Grünig; M Fort; D Rennick; F G Araujo
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

6.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

Review 7.  CVB-induced pancreatitis and alterations in gene expression.

Authors:  A I Ramsingh
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Intestinal epithelial cell proteome in IL-10 deficient mice and IL-10 receptor reconstituted epithelial cells: impact on chronic inflammation.

Authors:  Tanja Werner; Anna Shkoda; Dirk Haller
Journal:  J Proteome Res       Date:  2007-07-20       Impact factor: 4.466

9.  IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy.

Authors:  Susana Roque; Claudia Nobrega; Rui Appelberg; Margarida Correia-Neves
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

10.  Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice.

Authors:  J R Lane; D A Neumann; A Lafond-Walker; A Herskowitz; N R Rose
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

View more
  7 in total

1.  Dynamics of molecular responses to coxsackievirus B4 infection differentiate between resolution and progression of acute pancreatitis.

Authors:  Rui Gu; Anae Shampang; Andrew Reilly; Dusti Fisher; William Glass; Arlene I Ramsingh
Journal:  Virology       Date:  2012-03-11       Impact factor: 3.616

2.  Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.

Authors:  Rui Gu; Anae Shampang; Toufic Nashar; Manisha Patil; Deborah H Fuller; Arlene I Ramsingh
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

3.  Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.

Authors:  Sally Ann Huber; Brian Roberts; Mohamad Moussawi; Jonathan E Boyson
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

4.  Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile.

Authors:  Wing-Chi G Yeung; Ammira Al-Shabeeb; Chi Nam Ignatius Pang; Marc R Wilkins; Jacki Catteau; Neville J Howard; William D Rawlinson; Maria E Craig
Journal:  Diabetes       Date:  2012-04-03       Impact factor: 9.461

5.  Murine model of acute myocarditis and cerebral cortical neuron edema induced by coxsackievirus B4.

Authors:  Zhao-Peng Dong; Qian Wang; Zhen-Jie Zhang; Michael J Carr; Dong Li; Wei-Feng Shi
Journal:  Zool Res       Date:  2018-01-18

Review 6.  Risk factors for pancreatic cancer: underlying mechanisms and potential targets.

Authors:  Thomas Kolodecik; Christine Shugrue; Munish Ashat; Edwin C Thrower
Journal:  Front Physiol       Date:  2014-01-16       Impact factor: 4.566

Review 7.  T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?

Authors:  Qi Zhou; Xufeng Tao; Shilin Xia; Fangyue Guo; Chen Pan; Hong Xiang; Dong Shang
Journal:  Front Oncol       Date:  2020-03-24       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.